Pharma

As we race toward serialization deadlines, one of the questions we frequently get from pharma manufacturers, CMOs, 3PLs and repackagers is this: how do we really qualify total cost of ownership (TCO)? To take a line from Facebook, “it’s complicated.” In an attempt to simplify this complex...

Haris Kamal tends to seek out challenges and rarely shies away from risk and responsibility. “I’ll try anything at least once,” he says with a laugh. “I love adventure sports, all types of cuisines, and when I’m not working, it’s all about travel. That’s really...

With ever-expanding opportunities to advise companies about pharma serialization and traceability solutions, Scott Pugh doesn’t have much down time. Luckily for us, Scott is a valued member of Verify Brand's team as a strategic advisor, providing the company with guidance on its pharmaceutical offerings. Since 2007, Scott...

With the first round of DQSA regulations in place as of January 1, 2015—and the next set coming in 2017—it’s high time that pharmaceutical manufacturers and their business partners objectively assess their readiness. Waiting is no longer an option. At the same time, recklessly rushing...

A popular trend in the pharma industry’s approach to serialization is to run a pilot program to gain education and experience about how to operate in a serialized world. We’re all for the concept of pilots and agree they provide invaluable experience. However, we have...

Translate »